Breathe Well Live Well
Dairyland Express |
NBA Draft: Asthma deflating Kevon Looney's draft stock
Dairyland Express But according to a report, Looney's stock may be plummeting because of concerns over his asthma and its effect on his endurance and conditioning. Gery Woelfel of the Racine Journal Times reported that some NBA officials are now gauging Looney as a late … BUCKS BEAT Will asthma issue affect Looney's draft stock? |
View full post on asthma – Google News
|
BUCKS BEAT Will asthma issue affect Looney's draft stock?
Journal Times While Looney's asthma condition has raised red flags with some NBA teams, there are others who aren't overly concerned. They noted several NBA players over the years have had asthma and still had productive careers with the proper medication. |
View full post on asthma – Google News
|
KaloBios stock slides; to stop asthma study
MarketWatch KaloBios Pharmaceuticals Inc.'s (NASDAQ:KBIO) shares slumped after the company said it would discontinue development of a treatment for severe asthma, a move that followed disappointing Phase 2 results. Chief Executive Officer David Pritchard said … KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma … |
View full post on asthma – Google News
The Denver Channel |
Rigel drops asthma drug after trial fails, stock hits life-low
Reuters (Reuters) – Rigel Pharmaceuticals Inc said it will stop developing its experimental asthma drug after the therapy failed in a mid-stage trial, sending its shares down as much as 17 percent to a life-low. The failure of the inhaled drug is the latest … Rigel Shares Plunge After Asthma Drug Fails to Meet Goals Rigel shares slide after another drug flops in PhII asthma study Rigel Pharmaceuticals skids after asthma drug fails in study |
View full post on asthma – Google News
 The Age |
Pollen's blight returns for asthma, hay-fever sufferers
Stock and Land Professor Douglass said high grass pollen counts could also aggravate asthma, particularly when followed by a thunderstorm in a phenomenon known as ''thunderstorm asthma''. A rapid rise in humidity, which often precedes a thunderstorm, can cause … Hayfever season officially starts today with first pollen count |
View full post on asthma – Google News
|
SkyePharma launches asthma treatment in Germany
Stock Market Wire flutiform® was approved for the treatment of asthma maintenance therapy in Germany by its regulatory authority, Bundesinstitut für Arzneimittel und Medizinprodukte (BfARM), in July. Following the launch offlutiform® in Germany, a milestone of €4.0m is … SkyePharma Launches Flutiform In Germany – Quick Facts |
View full post on asthma – Google News
|
Approval given for SkyePharma's asthma treatment
Stock Market Wire StockMarketWire.com – SkyePharma (LSE SKP) has announced that the UK regulatory authority, the Medicines and Healthcare product Regulatory Agency (MHRA), has granted marketing authorisation for flutiform®, a combination product for the treatment of … SKYEPHARMA PLC : Half Yearly Report |
View full post on asthma – Google News
|
MediciNova Enters Into a $20 Million Common Stock Purchase Agreement With …
NASDAQ MediciNova will use the net proceeds from any sales of its stock to advance MediciNova's development activities for its lead programs, MN-221 (bedoradrine sulfate) in development for the treatment of acute asthma and chronic obstructive pulmonary … |
View full post on asthma – Google News
|
MediciNova Closes $7.5 Million Private Stock Sale to Kissei Pharmaceutical Co …
MarketWatch (press release) MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis, … |
View full post on asthma – Google News
|
Synairgen positive on asthma study latest
Stock Market Wire StockMarketWire.com – Synairgen plc, the respiratory drug discovery and development company with a particular focus on viral defence of the lungs, has provided an update on its Phase II asthma study. The company has announced that the outcome of the … |
View full post on asthma – Google News